4SC AG: Paediatric Investigation Plan waiver for resminostat from the UK MHRA received
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoceptor t…
BSI Life Sciences announces Harmony Clinical Research (HarmonyCR) as the latest client to adopt its cloud-based electron…
The US trade magazine "Healthcare Tech Outlook" recently named ibidi GmbH one of the ten best European manufacturers of…
Highlights: - Vielversprechende Wirkung der Minimalen Hemmkonzentration (Minimum Inhibitory Concentration – „MIC“) in d…
Wie jedes Jahr im April trifft sich die gesamte Health-IT-Branche vom 09. bis 11. April in Berlin auf der DMEA, Europas…
PELOBIOTECH GmbH, a leader in the field of biotechnology, announces a strategic partnership with HVD Life Science Vertri…
In der Session „New Drugs on the Horizon“ präsentiert Bayer präklinische und klinische Bildgebungsdaten zu Actinium-225…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…